Response to Letter to the Editor: Left Gastric Artery Embolization for Weight Loss—a Dead-End Procedure
- 8 Downloads
To the Editor,
We have been following, with great interest, the continued and balanced discussion surrounding the results published by Bai et al., “Bariatric embolization of the left gastric artery for the treatment of obesity: 9-month data in 5 patients.”
Our interest was piqued by two key points.
Firstly, Bai and colleagues reported their first experience with a new approach to treat obesity, bariatric embolization . There may be a treatment potential with this method that should not be hastily disqualified . In fact, it could fit into an existing treatment gap between those who qualify for pharma/conservative treatment of obesity and those who qualify for established bariatric/metabolic procedures .
Secondly, our interest in this discussion is amplified by our own ongoing prospective, randomized, sham-controlled, single-blind trial involving 40 patients (BMI 35–50 kg/m2) whom consented for left gastric artery embolization (LGAE) using 300–500-μm microspheres through the...
Compliance with Ethical Standards
Conflict of Interest
Martin Fried was Principal Investigator of the RCT and Nodar Kipshidze was Endobar Solutions LLC Part-time consultant for statistical analysis.
Ethical Approval Statement
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed Consent Statement
Informed consent was obtained from all individual participants included in the study.